EMA (EU)
EVENT
EMA multi-stakeholder workshop on supporting innovation in cardiovascular medicines and medical devices in the EU
Published: 7/13/2026Detected: 6/29/2026
Summary preview
Hosts an EMA multi-stakeholder workshop to align cardiovascular (CV) medicine and medical device innovation with EU regulatory expectations, focusing on how regulation and innovation interact.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountcardiology
clinical
safety
quality
clinical
labeling
manufacturing
#EMA workshop
#cardiovascular medicines
#medical devices
#real-world data
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system10/12/2026
- First European Medicines Agency (EMA) - International Society for Cell and Gene Therapy (ISCT) bilateral meeting10/12/2026
- Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 202610/8/2026
- PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 202610/8/2026
- SPOR and XEVMPD status update webinar - Q4 202610/7/2026